Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging ...

Dear Dr. Roach: I am 86 years old. Nine years ago I overcame non-Hodgkin's lymphoma. Now, my oncologist tells me I have multiple myeloma. I read up about it, and ...

Multiple myeloma (MM) is the second most commonly diagnosed hematologic malignancy. In 2007, there will be an estimated 19,900 new cases of MM and 10,790 deaths due to MM in the United States. [1] ...

England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological cancer multiple myeloma, in the latest stage of the medicine's renaissance.

For example, research into fluoroscopically guided bone marrow aspiration and biopsy using a drill-powered needle reported high diagnostic success rates and negligible complication incidence, thus ...

Darzalex as monotherapy was investigated in two main studies involving multiple myeloma patients whose disease relapsed after, or was refractory to, at least two previous treatments, including a ...

How Kentucky football could go about filling Vince Marrow’s multiple roles Jon Hale June 9, 2025, 3:18 PM PDT · 3 min read ...

Vince Marrow’s expected move to Louisville leaves Kentucky football with key roles to fill, raising questions about Mark Stoops’ future leadership.

Bone marrow or stem cell transplants Who Gets Indolent Lymphomas? No one knows what causes non-Hodgkin lymphomas. There are some known risk factors, but these vary according to the type of lymphoma.